News Relief Therapeutics Holding SA

Equities

RLF

CH1251125998

End-of-day quote Swiss Exchange Other stock markets 18:00:00 2024-04-28 EDT			5-day change	1st Jan Change
1.3 ^CHF	0.00%		+3.17%	-34.67%

08:01am	Relief Therapeutics' FY23 Loss Widens; Revenue Edges Down	MT
03-22	Sector Update: Health Care Stocks Steady Pre-Bell Friday	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Relief Therapeutics' FY23 Loss Widens; Revenue Edges Down	02:01am	MT
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting	03-28	AQ
Sector Update: Health Care Stocks Steady Pre-Bell Friday	03-22	MT
Sector Update: Health Care	03-22	MT
Eton Pharmaceuticals Acquires US Rights to Phenylketonuria Dietary Management Product	03-22	MT
Relief Therapeutics Grants Eton Pharmaceuticals Exclusive License for US Commercialization of Golike	03-22	MT
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE	03-22	CI
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria	03-22	AQ
Relief Therapeutics Extends CHF50 Million Share Subscription Facility with Largest Shareholder	02-28	MT
Relief Therapeutics Holding SA announced that it expects to receive CHF 50 million in funding from Global Emerging Markets and another investor	02-27	CI
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth	12-06	AQ
Relief Therapeutics to Run Commercial Operations Via Partnership Model	12-05	MT
Relief Therapeutics Announces CEO Transition	11-23	AQ
Relief Therapeutics CEO to Leave; Interim Successor Takes Over	11-22	MT
Relief Therapeutics Holding Sa Announces CEO Changes	11-22	CI
Relief Therapeutics announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone	23-10-11	AQ
Relief Therapeutics Meets Outstanding ADR Requirement for Nasdaq Listing	23-10-10	MT
Relief Therapeutics Reports Half-Year 2023 Financial Results and Provides Corporate Update	23-09-18	AQ
Relief Therapeutics Holding AG(SWX:RLF) dropped from S&P Global BMI Index	23-09-18	CI
Relief Therapeutics Holding AG Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Relief Therapeutics Holding SA

Equities

RLF

CH1251125998

Summary

Filters